Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Vistagen Therapeutics, Inc. | CHIEF FINANCIAL OFFICER | Common Stock | 3.59K | $10.6K | $2.96 | Jun 28, 2024 | Direct |
Vistagen Therapeutics, Inc. | CHIEF FINANCIAL OFFICER | Stock Option (Right to Buy) | 150K | Jun 24, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
VTGN | Vistagen Therapeutics, Inc. | Jun 28, 2024 | 1 | $10.6K | 4 | Jul 2, 2024 | CHIEF FINANCIAL OFFICER |
VTGN | Vistagen Therapeutics, Inc. | Jun 24, 2024 | 1 | $0 | 4 | Jun 26, 2024 | CHIEF FINANCIAL OFFICER |
VTGN | Vistagen Therapeutics, Inc. | Aug 21, 2023 | 1 | $0 | 4 | Aug 23, 2023 | CHIEF FINANCIAL OFFICER |
VTGN | Vistagen Therapeutics, Inc. | Aug 21, 2023 | 0 | $0 | 3 | Aug 23, 2023 | CHIEF FINANCIAL OFFICER |